This health monitoring study validates continuous biosensing technology across diverse patient populations and conditions. We demonstrate that wearable biosensors can reliably capture clinically meaningful health data in real-world settings, with high accuracy and user acceptance.
While laboratory validation of biosensors is essential, real-world performance in patient populations is equally important. This study evaluates continuous biosensing technology across 500 patients with varying health conditions, ages, and lifestyles to assess practical performance and reliability.
We enrolled 500 patients across five diagnostic categories including mast cell activation syndrome, connective tissue disorders, autonomic dysfunction, neuroinflammatory conditions, and healthy controls. Participants wore continuous biosensors for 12 weeks while reporting outcomes through mobile apps and clinical visits.
Device compliance averaged 94.2% across the study population, with no significant differences by age or diagnosis. Data quality remained high even during routine activities, with signal loss occurring in only 2.1% of measurement intervals.
When compared to reference laboratory measurements obtained weekly, the biosensor demonstrated 96.3% accuracy for biomarker detection and 95.8% accuracy for physiological measurements. Performance was consistent across diverse patient populations.
Importantly, we identified subgroups with particularly high data quality (>98% complete intervals) and refined device positioning recommendations based on body morphology. User satisfaction scores averaged 8.2/10, with 87% of patients reporting the device was comfortable to wear continuously.
These results demonstrate that continuous biosensing is practical and reliable for real-world clinical use. The high accuracy, compliance, and user satisfaction support deployment in clinical research and eventually clinical care settings.
Continuous biosensors are technically and clinically valid for long-term health monitoring in diverse patient populations. Future work should focus on integrating these devices into clinical workflows and demonstrating improved outcomes compared to conventional monitoring approaches.